Ovarian cancer resistance to PARPi and platinum-containing chemotherapy

Epithelial ovarian cancer remains the most lethal female malignancy despite options for systemic therapy and the emergence of targeted therapies. Although initial response to therapy is observed, recurrence and ultimately chemoresistance result in overall therapeutic failure. This pattern has been e...

Descripción completa

Detalles Bibliográficos
Autores principales: Summey, Rebekah, Uyar, Denise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511803/
https://www.ncbi.nlm.nih.gov/pubmed/36176755
http://dx.doi.org/10.20517/cdr.2021.146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511803/
https://www.ncbi.nlm.nih.gov/pubmed/36176755
http://dx.doi.org/10.20517/cdr.2021.146

Ejemplares similares